Zoloft®
Sertraline
Version 2025-04 · Last reviewed April 1, 2025 · Methodology
List Price
$80
With Insurance
$4-15
FDA Black Box Warning
INCREASED SUICIDAL THOUGHTS IN UNDER 25
Monitor closely in first months. Risk highest in first 1-4 weeks.
Strict Contraindications
How It Works
Sertraline increases the amount of serotonin available between nerve cells by blocking its reuptake. Unlike Paxil, sertraline does this very selectively — it has minimal effect on other receptor systems, which is why it has fewer side effects.
Why the side effects happen
Sertraline is one of the most selective SSRIs — it primarily affects serotonin with minimal off-target receptor effects. Initial side effects (nausea, agitation, insomnia) come from serotonin flooding the GI tract and limbic system before the brain adapts. Sexual dysfunction is a direct consequence of excess synaptic serotonin suppressing dopamine pathways involved in sexual function.
When Will I Feel It?
Partial improvement often noticeable at 1–2 weeks. Full antidepressant effect takes 4–8 weeks. Anxiety disorders may take longer.
Side effects peak (nausea, restlessness, initial anxiety worsening). Take with food. Effects are temporary.
Sleep, energy, and appetite often improve before mood fully lifts. Many patients feel "partially better" during this phase.
Core depressive and anxiety symptoms begin resolving. Many guidelines consider 8 weeks the minimum adequate trial.
Full anxiety disorder response (OCD, PTSD, panic disorder typically require higher doses and longer trials than depression).
Adherence Note
Feeling worse in the first 1–2 weeks doesn't mean the drug is wrong for you — it's a known initial activation period. Clinical guidelines define 8 weeks at a therapeutic dose as the minimum adequate trial for SSRIs, since earlier evaluations do not reflect the drug's full pharmacological effect.
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Common Side Effects
While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.
Nausea
26%Take with food; usually improves after 1-2 weeks
Sexual dysfunction (decreased libido, delayed orgasm)
25-40%Very common; discuss with doctor; dose reduction or drug holiday may help
Insomnia or drowsiness
20%Take in morning for insomnia or evening for drowsiness
Diarrhea
20%Usually improves; take with food
Dry mouth
16%Sip water frequently; sugar-free gum helps
Sweating (excessive)
12%Usually worse at night; wear breathable clothing
Tremors / shakiness
11%Report to doctor; dose adjustment may help
Fatigue / tiredness
10%Often improves after first 2-4 weeks
Headache
9%Common at start; usually temporary
Weight gain
8-15% with long-term useOften gradual; monitor weight; exercise helps
Serious Adverse Effects
- • Suicidal ideation (especially in under-25, first weeks) — Black Box
- • Serotonin syndrome (with other serotonergic drugs)
- • Bleeding risk (especially GI with NSAIDs)
- • Mania/hypomania (if bipolar undiagnosed)
- • Severe discontinuation syndrome
- • Hyponatremia (low sodium)
Drug Interactions
Major Interactions (Avoid)
Moderate Interactions (Caution)
Food Interactions
When to Contact Your Doctor
This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician — do not wait for your next scheduled appointment.
Contact soon if you notice
- Suicidal ideation (especially in under-25, first weeks) — Black Box
- Serotonin syndrome (with other serotonergic drugs)
- Bleeding risk (especially GI with NSAIDs)
- Mania/hypomania (if bipolar undiagnosed)
- "Brain zaps" — electric shock sensations in the head
Also discuss if you want to
- Review whether this medication is still appropriate for you
- Consider dosage adjustments based on response
- Explore lifestyle or non-drug alternatives
- Understand stopping or tapering options
- Plan monitoring labs and follow-up
In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.
Special Populations
Safety classifications for specific groups — discuss with your provider before use.
PPHN risk if used near delivery. Weigh risks vs. untreated depression.
Low levels in milk; consider benefits vs. risks.
Mood swings, irritability, anxiety, sadness, and sleep problems during perimenopause are commonly driven by estrogen and progesterone fluctuations — not clinical depression. SSRIs are frequently prescribed when the root cause is hormonal. Hormone therapy may address these symptoms more directly. Ask your doctor whether a hormonal evaluation should happen before starting an antidepressant.
FDA approved for OCD in children. Black Box warning applies.
Risk of hyponatremia and falls. Start low.
Generally safe; monitor
FDA Adverse Event Reports
Patient-filed reports from the FDA FAERS database · refreshed daily
Community Reports
User-reported experiences — anonymous & anecdotal
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Metabolic & Lifestyle Alternatives
🧘 Evidence-Based Non-Drug Depression Treatments
Structured exercise showed antidepressant-comparable effects in several randomized trials for mild-to-moderate depression
Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.
Aerobic exercise
3x/week 45 min
Equal to sertraline in SMILE trial
CBT (Cognitive Behavioral Therapy)
12-20 sessions
Equal efficacy to meds; lower relapse rate
Omega-3 (EPA dominant)
EPA 1-2g/day
Meta-analysis: significant antidepressant effect
Sleep optimization
7-9 hours consistent schedule
Sleep deprivation is causal for depression
How It Compares
Sertraline is generally considered one of the best-balanced SSRIs — effective across multiple indications with a favorable side effect profile. Often recommended as the starting SSRI by UK NICE and other guidelines.
Strengths
- Effective for depression, anxiety, OCD, PTSD, panic disorder, PMDD
- Relatively weight-neutral (less gain than paroxetine)
- Cheaper than most alternatives
- Half-life of 26 hours — manageable discontinuation compared to paroxetine
- Minimal CYP drug interactions at standard doses
Weaknesses
- Sexual dysfunction (30–40%)
- Initial nausea and activation
- Modest CYP2D6 inhibition at higher doses (150–200mg)
Clinically Preferred Alternatives
Global Prescribing & Pricing
US antidepressant prescribing rates are approximately 4× higher than comparable European countries, despite similar reported prevalence of depression
United States
$10–20 (generic)/mo
13% of adults on antidepressants — highest in the world
Any physician can prescribe; no therapy requirement before or alongside medication
Varies by plan
United Kingdom
~$1–4/mo
~7% of adults — NICE therapy-first model
NICE mandates CBT or talking therapy before SSRIs for mild-to-moderate depression; free IAPT program
Fully covered by NHS
Germany
~$9–22/mo
~6% of adults — integrated care approach
GKV subsidizes psychotherapy wait times; stepped care model — therapy then medication
Covered by GKV
Sweden
~$3–10/mo
~6.5% of adults — exercise and therapy prioritized
Exercise on prescription (Fysisk aktivitet på recept) — doctors prescribe structured exercise programs
Covered by Landsting
Netherlands
~$5–12/mo
~5% of adults — stepped care model
Mandatory stepped care: lifestyle and self-help first, then therapy, then medication — no shortcuts
Covered by Zorgverzekering
The UK's IAPT program (Improving Access to Psychological Therapies) provides free CBT to all NHS patients before SSRIs are considered for mild/moderate depression — achieving equivalent outcomes with significantly lower prescribing rates. Sweden goes further: doctors can literally prescribe structured exercise programs.
Clinical Trials & Funding
Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid — they undergo the same FDA review — but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.
Funding Sources
Pfizer originally funded major trials. Publication bias: negative studies often unpublished. FDA analysis showed average effect size modest (NNT ~10, but much less in mild-moderate depression).
Declared Conflicts of Interest
APA receives significant pharmaceutical sponsorship. Many depression researchers receive pharma consulting fees. The "chemical imbalance" theory was largely a marketing claim without strong scientific backing.
Key Efficacy Results
Response rate 40-50%; remission rate 30-35%; placebo response ~30%
Referenced Studies
Each study carries a Cochrane RoB-2 risk-of-bias badge — tap the badge for details.
Evidence & Transparency
Cochrane RoB-2 (Risk of Bias)
Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗
CMS Open Payments
Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears" — never definitive clinical claims. CMS Open Payments ↗
Live Clinical Trials
Live from ClinicalTrials.gov · refreshed every 4 hours
Currently enrolling, active, and recently completed studies involving Sertraline. Data is pulled directly from the U.S. National Library of Medicine.
Recent Research
Live from PubMed · peer-reviewed literature · refreshed every 4 hours
Most recently indexed clinical trials and systematic reviews mentioning Sertraline in PubMed.
Source Documentation
Structured citations for referenced clinical trials
Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.
| Trial | Registry ID | Cite |
|---|---|---|
| STAR*D (NIH) | NCT00021528 | |
| PANDA (Sertraline vs Placebo) | ISRCTN17517946 |
Bias ratings use Cochrane RoB-2 methodology. Editorial assessment — not a certified Cochrane review.
Our MethodologyMedical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Stopping This Medication Safely
SSRI discontinuation syndrome is severe and common with sertraline. Abrupt stopping causes electric shock sensations ("brain zaps"), severe dizziness, flu-like symptoms, rebound anxiety, and intense irritability.
What Published Research Shows About Stopping This Medication
This summarizes what published research documents — it is not personal medical advice. Any changes to your medication require discussion with your prescribing physician.
- ·Research shows even missing 2–3 doses can trigger discontinuation symptoms — abrupt stopping is not documented as safe
- ·Published tapering schedules describe reductions of no more than 10–25mg every 2–4 weeks
- ·For long-term users (2+ years), research supports extending the total stopping process to 3–6 months
- ·Research supports having CBT or therapy established before beginning dose reduction
- ·Some patients use liquid sertraline for micro-tapering (1–5% weekly reductions) — a practice supported by emerging research
Warning Symptoms — Contact Your Doctor If You Experience:
- "Brain zaps" — electric shock sensations in the head
- Severe dizziness or vertigo
- Flu-like symptoms without fever
- Extreme irritability or tearfulness
- Vivid nightmares
- Anxiety significantly worse than original symptoms
Never change or stop a medication without consulting your prescribing physician.
Questions for Your Doctor
Questions to Ask
- 1.Should we try therapy first or alongside?
- 2.How will we know if it's working?
- 3.What are the discontinuation effects?
- 4.What's the plan if I want to stop?
Lab Tests to Request
- Thyroid function (TSH)
- Vitamin D
- CBC
- Sodium (Na+) with elderly
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Frequently Asked Questions About Zoloft®
- What is Zoloft® used for?
- Zoloft® (Sertraline) is a SSRI (Selective Serotonin Reuptake Inhibitor) manufactured by Generic. FDA-approved indications include: Major depressive disorder; OCD; Panic disorder; PTSD; Social anxiety; PMDD.
- What are the common side effects of Zoloft®?
- Common side effects of Zoloft® include: Nausea (26%); Sexual dysfunction (decreased libido, delayed orgasm) (25-40%); Insomnia or drowsiness (20%); Diarrhea (20%); Dry mouth (16%).
- How much does Zoloft® cost?
- Zoloft® list price is approximately $80. With insurance it typically costs $4-15; without insurance approximately $10-25.
- Who funded the clinical trials for Zoloft®?
- Pfizer originally funded major trials. Publication bias: negative studies often unpublished. FDA analysis showed average effect size modest (NNT ~10, but much less in mild-moderate depression).
- How strong is the clinical evidence for Zoloft®?
- Key studies: STAR*D trial, Cipriani meta-analysis (Lancet 2018). Response rate 40-50%; remission rate 30-35%; placebo response ~30% Potential conflicts of interest: APA receives significant pharmaceutical sponsorship. Many depression researchers receive pharma consulting fees. The "chemical imbalance" theory was largely a marketing claim without strong scientific.
- Are there non-drug alternatives to Zoloft®?
- Structured exercise showed antidepressant-comparable effects in several randomized trials for mild-to-moderate depression See the Alternatives tab for full details.
Get notified when we update Zoloft®
We'll email you when new evidence, safety updates, or alternatives are added.
No spam. Unsubscribe anytime.